BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9632216)

  • 1. Isradipine combined with naltrexone persistently reduces the reward-relevant effects of cocaine and alcohol.
    Cramer CM; Gardell LR; Boedeker KL; Harris JR; Hubbell CL; Reid LD
    Pharmacol Biochem Behav; 1998 Jun; 60(2):345-56. PubMed ID: 9632216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination of isradipine and naltrexone blocks cocaine's enhancement of a cocaine place preference.
    Cramer CM; Hubbell CL; Reid LD
    Pharmacol Biochem Behav; 1998 Aug; 60(4):847-53. PubMed ID: 9700968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isradipine blocks cocaine's ability to facilitate pressing for intracranial stimulation.
    Gonzales PM; Boswell KJ; Hubbell CL; Reid LD
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1117-22. PubMed ID: 9408222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amlodipine, a calcium channel inhibitor, and cocaine and ethanol's reinforcing effects.
    Gardell LR; Reid ML; Cavallero CA; Burgess SE; Wallace RF; Hubbell CL; Reid LD
    Pharmacol Biochem Behav; 1999 Nov; 64(3):567-72. PubMed ID: 10548273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responding for rewarding brain stimulation: cocaine and isradipine plus naltrexone.
    Pabello NG; Hubbell CL; Cavallaro CA; Barringer TM; Mendez JJ; Reid LD
    Pharmacol Biochem Behav; 1998 Oct; 61(2):181-92. PubMed ID: 9738534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isradipine and naltrexone in combination with isradipine interact with a period of abstinence to reduce rats' intakes of an alcoholic beverage.
    Gardell LR; Reid LD; Boedeker KL; Liakos TM; Hubbell CL
    Alcohol Clin Exp Res; 1997 Dec; 21(9):1592-8. PubMed ID: 9438517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of naltrexone and fluoxetine on rats' propensity to take alcoholic beverage.
    Gardell LR; Whalen CA; Chattophadyay S; Cavallaro CA; Hubbell CL; Reid LD
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1435-9. PubMed ID: 9394115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isradipine in combination with naltrexone as a medicine for treating cocaine abuse.
    Reid LD; Pabello NG; Cramer CM; Hubbell CL
    Life Sci; 1997; 60(8):PL119-26. PubMed ID: 9042392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of naltrexone supersensitivity during food-maintained responding enhances naltrexone's ability to reduce ethanol-maintained responding.
    Williams KL
    Alcohol Clin Exp Res; 2007 Jan; 31(1):39-47. PubMed ID: 17207100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research with rats germane to medication for alcoholism: consequences of noncompliance.
    Reid ML; Hubbell CL; Douglass AV; Boedeker KL; Reid LD
    Alcohol; 2001 Jul; 24(3):169-77. PubMed ID: 11557302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isradipine produces neither a conditioned place preference nor aversion.
    Calcagnetti DJ; Schechter MD
    Life Sci; 1994; 54(6):PL81-6. PubMed ID: 8295483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periodic naltrexone and propensity to take alcoholic beverage.
    Reid LD; Gardell LR; Chattopadhyay S; Hubbell CL
    Alcohol Clin Exp Res; 1996 Nov; 20(8):1329-34. PubMed ID: 8947306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra-low-dose naltrexone reduces the rewarding potency of oxycodone and relapse vulnerability in rats.
    Leri F; Burns LH
    Pharmacol Biochem Behav; 2005 Oct; 82(2):252-62. PubMed ID: 16182352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-exposure to alcohol does not sensitize to the rewarding effects of cocaine.
    Le Pen G; Duterte-Boucher D; Daoust M; Costentin J
    Neuroreport; 1998 Aug; 9(12):2887-91. PubMed ID: 9760140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm.
    Cordery SF; Taverner A; Ridzwan IE; Guy RH; Delgado-Charro MB; Husbands SM; Bailey CP
    Addict Biol; 2014 Jul; 19(4):575-86. PubMed ID: 23240906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocaine, but not alcohol, reinstates cocaine-induced place preferences.
    Busse GD; Riley AL
    Pharmacol Biochem Behav; 2004 Aug; 78(4):827-33. PubMed ID: 15301942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of drinking sweetened water following calcium channel blockade.
    Calcagnetti DJ; Schechter MD
    Brain Res Bull; 1992 Jun; 28(6):967-73. PubMed ID: 1386279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The modulation of cocaine-induced conditioned place preferences by alcohol: effects of cocaine dose.
    Busse GD; Lawrence ET; Riley AL
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):149-55. PubMed ID: 14687869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of isradipine on cocaine-induced subjective mood.
    Johnson BA; Roache JD; Ait-Daoud N; Wells LT; Mauldin JB
    J Clin Psychopharmacol; 2004 Apr; 24(2):180-91. PubMed ID: 15206666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone and nalmefene attenuate cocaine place preference in male mice.
    Windisch KA; Reed B; Kreek MJ
    Neuropharmacology; 2018 Sep; 140():174-183. PubMed ID: 30048644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.